Clinical Trial Update: Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for corneal collagen crosslinking with riboflavin/dextran (and hypotonic riboflavin) in progressive keratoconus and corneal ectasi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• hypotonic riboflavin (riboflavin (hypotonic formulation))
• riboflavin/dextran (riboflavin/dextran)

Snippet

Sponsor: Cornea and Laser Eye Institute | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: UNKNOWN